| UCSF Magazine

UCSF Ophthalmologist Named Editor-in-Chief of Academic Journal

Saras Ramanathan, MD, has been appointed as editor-in-chief of the Journal of Academic Ophthalmology (JAO). JAO is the official publication of the Association of University Professors of Ophthalmology (AUPO). It is a peer-reviewed, online, open-access publication that serves as a national and international forum for the publication and scholarly exchange of ideas and information of interest to academic ophthalmology.

Jumbled Proteins Paint a Bold Target on the Backs of Brain Tumors

UCSF scientists have found that some cancers, like brain cancer, make unique, jumbled proteins that make them stand out. These newly recognized cancer-specific proteins, or antigens, could speed the development of potent immunotherapies that recognize and attack hard-to-treat tumors.

California Sees an ‘Alarming’ Rise in Advanced Prostate Cancer, UCSF Study Finds

Is U.S. Prepared for Bird Flu’s Spread in Humans? One Expert Has Concerns

Worst Flu Season in Years Swamps California: ‘Particularly Long and Difficult’

‘An Attack on Science’: UC, California Fight Trump Cuts to NIH Health Research Funding

Fake Pharmaceuticals Laced with Fentanyl Are a Global Health Crisis

International Stroke Conference Features UCSF Experts

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease and brain health. This year’s meeting was held Feb. 5–7, 2025, in Los Angeles.

How Artificial Intelligence is Fostering Human Connection in Health Care

AI has come to doctors’ office near you. With patients’ consent, physicians and patients across the country are increasingly turning to artificial intelligence to note-take during visits to foster better discussions during visits, and help save time afterwards.

Could a Bacteria-Killing Virus Help Solve Antibiotic Resistance?

UCSF scientists are taking the first steps toward creating a new type of antibiotic that uses an unusual virus to defeat antibiotic-resistant bacteria.

Subscribe to